XNW5004
Asset
- Stage
- Phase 1
- Modality
- Small molecule
- Target
- Not known
- 2
- Indications
- 1,324
- Trials
- 1
- Developer
Indications
2Non-Hodgkin lymphoma
Phase 1, Recruiting, NCT07730515, clinicaltrials.gov, 7 Oct 2026
Peripheral t cell lymphoma
Phase 1, Recruiting, NCT07730515, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Trials1,324
- Evidence for its targets1
- Competitors7
- Signals7
Every asset’s record: target, stage, trials and the evidence behind it.